Kahn Swick & Foti Investigates HilleVax Sale Price and Process

New York and New Orleans—Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is examining the proposed acquisition of HilleVax, Inc. (Nasdaq: HLVX) by XOMA Royalty Corporation (Nasdaq: XOMA). Under the deal, HilleVax shareholders are set to receive $1.95 in cash per share along with a non-transferable contingent value right, which could entitle them to additional payments under certain conditions. The law firm aims to assess whether the offered price and the process leading to this transaction are fair and if the valuation accurately reflects the company's worth. They are also checking whether the deal might undervalue HilleVax. If you believe the sale undervalues the company or wish to explore your legal options, you can contact KSF's Managing Partner Lewis S. Kahn at [email protected] or call toll-free at 855-768-1857. More information is available at https://www.ksfcounsel.com/cases/nasdaqgs-hlvx/. Please note that as this is a tender offer, timing may be critical. To learn more about Kahn Swick & Foti, LLC, visit www.ksfcounsel.com. Kahn Swick & Foti, LLC 1100 Poydras St., Suite 960 New Orleans, LA 70163 Follow us on social media...